nelfinavir has been researched along with Liver Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lo Caputo, S; Maserati, R; Pan, A; Regazzi, MB; Seminari, E; Villani, P | 1 |
| Badley, A; Bulman, D; Cameron, DW; Carignan, G; Fyke, K; Gallicano, K; Khaliq, Y; Seguin, I | 1 |
2 other study(ies) available for nelfinavir and Liver Diseases
| Article | Year |
|---|---|
High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver Diseases; Male; Nelfinavir; Oxazines; Reverse Transcriptase Inhibitors; Stavudine | 1999 |
Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Confidence Intervals; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; HIV Infections; HIV Protease Inhibitors; Humans; Linear Models; Liver Diseases; Male; Mixed Function Oxygenases; Nelfinavir | 2000 |